Cargando…

Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis

BACKGROUND: Malignancies in the urinary tract and the kidney graft are quite common after kidney transplantation. In some selected cases tumours develop from donor-derived tissue. OBJECTIVES: We hypothesised that there is a clinical value to investigate donor/recipient origin in urologic malignancie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hellström, Vivan, Tufveson, Gunnar, Loskog, Angelica, Bengtsson, Mats, Enblad, Gunilla, Lorant, Tomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491581/ https://www.ncbi.nlm.nih.gov/pubmed/36129920 http://dx.doi.org/10.1371/journal.pone.0271293

Ejemplares similares

Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti‐HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients
por: Lorant, Tomas, et al.
Publicado: (2018)

Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy
por: Wenthe, Jessica, et al.
Publicado: (2021)

Urological evaluation prior to renal transplantation
por: Ciszek, Michał
Publicado: (2015)

Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy
por: Sjöholm, Therese, et al.
Publicado: (2022)

Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy
por: Sjöholm, Therese, et al.
Publicado: (2023)

Safety and efficacy of eculizumab for the prevention of antibody‐mediated rejection after deceased‐donor kidney transplantation in patients with preformed donor‐specific antibodies
por: Glotz, Denis, et al.
Publicado: (2019)

Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia
por: Christiansson, Lisa, et al.
Publicado: (2013)

Relative and absolute cancer risks among Nordic kidney transplant recipients—a population‐based study
por: Benoni, Henrik, et al.
Publicado: (2020)

Independent Risk Factors for Urological Complications after Deceased Donor Kidney Transplantation
por: Slagt, Inez K. B., et al.
Publicado: (2014)

Donor-Derived Urothelial Carcinoma in Renal Transplant Recipients
por: Qian, Zhiyu, et al.
Publicado: (2022)

Evolution of Pediatric Urology at Sindh Institute of Urology and Transplantation
por: Sultan, Sajid
Publicado: (2014)

UROLOGY AND RENAL MEDICINE
Publicado: (1971)

The standard of urological consultation of patients qualified for renal transplant – a review
por: Antoniewicz, Artur Andrzej, et al.
Publicado: (2015)

Urological complications after renal transplantation – a single centre experience
por: Krajewski, Wojciech, et al.
Publicado: (2016)

Prosthetic urology: past, present, and future
por: Tsambarlis, Peter N, et al.
Publicado: (2019)

Donor-derived fatal hyperinfection strongyloidiasis in renal transplant recipient
por: Cipriano, Ana, et al.
Publicado: (2020)

Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles
por: Loskog, Angelica
Publicado: (2015)

Urological Complications Associated With Pyeloureterostomy Without Ipsilateral Nephrectomy in Renal Transplant Recipients
por: Neto, Hernani M., et al.
Publicado: (2022)

Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
por: Wenthe, Jessica, et al.
Publicado: (2020)

Liver Grafts for Transplantation from Donors with Diabetes: An Analysis of the Scientific Registry of Transplant Recipients Database
por: Zheng, Jun, et al.
Publicado: (2014)

Pancreas grafts for transplantation from donors with hypertension: an analysis of the scientific registry of transplant recipients database
por: Hu, Zhen-Hua, et al.
Publicado: (2018)

Renal Transplantation from Elderly Living Donors
por: Akoh, Jacob A., et al.
Publicado: (2013)

Donor Transmission of Melanoma Following Renal Transplant
por: Chen, Kathryn T., et al.
Publicado: (2012)

Uterine Tissue Engineering and the Future of Uterus Transplantation
por: Hellström, Mats, et al.
Publicado: (2016)

Clinical Characteristics of Renal Transplant Recipients that Underwent Urologic Surgery for de novo Disease Before and After Transplantation
por: Bae, Kwan-Sik, et al.
Publicado: (2005)

Correction: Liver Grafts for Transplantation from Donors with Diabetes: An Analysis of the Scientific Registry of Transplant Recipients Database
Publicado: (2014)

Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients
por: Sarén, Tina, et al.
Publicado: (2023)

Donor-Recipient Size Mismatch in Paediatric Renal Transplantation
por: Donati-Bourne, J., et al.
Publicado: (2014)

Effectiveness of a 5-Day External Stenting Protocol on Urological Complications After Renal Transplantation
por: Minnee, Robert C., et al.
Publicado: (2009)

The development and current status of minimally invasive surgery to manage urological complications after renal transplantation
por: Sabnis, Ravindra B., et al.
Publicado: (2016)

Heparin Conjugate Pretreatment of Kidneys From Deceased Donors Before Transplantation: Results From the First-in-human Randomized Phase I Trial
por: Sedigh, Amir, et al.
Publicado: (2022)

Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models
por: Wenthe, Jessica, et al.
Publicado: (2023)

Induction with rATG versus No-induction in Deceased Donor Renal Transplantation – A Retrospective Observational Study
por: Dwivedi, Rohan, et al.
Publicado: (2022)

Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
por: Niinivirta, Marjut, et al.
Publicado: (2020)

Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
por: Niinivirta, Marjut, et al.
Publicado: (2017)

Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib
por: Niinivirta, Marjut, et al.
Publicado: (2017)

Simultaneous living donor orthotopic renal transplantation and bilateral nephrectomy for recurrent renal cell carcinoma and renal failure: case report and review of literature
por: Novotny, Robert, et al.
Publicado: (2018)

The Scientific Value of Abstracts on Prostate Cancer Presented at the European Association of Urology Congresses
por: Ataei, Jasmin, et al.
Publicado: (2021)

Tumoral Pyruvate Kinase L/R as a Predictive Marker for the Treatment of Renal Cancer Patients with Sunitinib and Sorafenib
por: Niinivirta, Marjut, et al.
Publicado: (2019)

Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection
por: Sherman, Amy C, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_netbv8osq5ls90b1qpq8k6edav